Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Pembrolizumab for Patients with High-Risk Melanoma Without Signs of Metastasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • Study on Stopping Nivolumab or Pembrolizumab in Advanced Melanoma Patients After Achieving a Response

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study of MC2 TCR T Cell Therapy and Epigenetic Drug Treatment for Patients with Advanced Melanoma or Head and Neck Cancer

    Recruiting

    1 1 1
    The Netherlands
  • Study on Using Perflubutane for Sentinel Node Detection in Patients with Breast Cancer, Melanoma, or Head and Neck Cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

    Recruiting

    1 1 1
    Investigated Drugs:
    Belgium France Germany Ireland Italy The Netherlands +3
  • Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on the Effectiveness of Pembrolizumab and Ipilimumab in Melanoma Patients with Brain Metastases Requiring Steroid Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Denmark
  • Study of Vemurafenib, Cobimetinib, and Atezolizumab for Patients with High-Risk, Surgically Removable BRAF Mutated and Wild-Type Melanoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Study on Changes in [18F]F-AraG Uptake After Radiotherapy in Patients with Non-Small Cell Lung Cancer, Melanoma, Breast Cancer, and Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on the Effect of Nivolumab and Melphalan in Patients with In-Transit Melanoma Metastases

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands Sweden